Last updated on December 2018

Twelve -Month Study Observing How Insulin-na ve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo After Oral Antidiabetic Drug Failure the Side Effect of Toujeo and The Cost.

Brief description of study

Primary Objective:

Assess effectiveness of insulin glargine (U300) in achieving glycemic goal measured by hemoglobin A1c (HbA1c).

Secondary Objectives:

  • Assess effectiveness in achieving glycemic goal measured by HbA1c;
  • Assess effectiveness on change in HbA1c, fasting plasma glucose (FPG) and self-monitored plasma glucose (SMPG) ;
  • Assess requirement for intensification of therapy by additional antidiabetics.
  • Assess incidence of hypoglycemia;
  • Assess other safety endpoints: adverse events (AEs), serious adverse events (SAEs);
  • Assess change in body weight.

Detailed Study Description

Patients will be observed for one year

Clinical Study Identifier: NCT03703869

Contact Investigators or Research Sites near you

Start Over

Trial Transparency email recommended (Toll ...

Investigational Site Number 6080001
Dasmarinas Cavite, Philippines
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.